Literature DB >> 22963225

Tendon regeneration in human and equine athletes: Ubi Sumus-Quo Vadimus (where are we and where are we going to)?

Jan H Spaas1, Deborah J Guest, Gerlinde R Van de Walle.   

Abstract

Tendon injuries are one of the most common orthopaedic problems in both human and equine athletes. When a damaged tendon heals naturally, it loses a substantial part of the original strength and elasticity. Therefore, tendons recover structurally (reparation) but not functionally (regeneration) after conservative medical or surgical treatment. Since the structure and matrix composition of human and equine tendons share many similarities, the nature of tendon injuries are also strongly comparable in both species. Therefore, the evaluation of regenerative therapies in horses may have applications for future human medicine and vice versa. The current review focuses briefly on the physiology of human and equine tendon in order to better comprehend the modus operandi of this structure under pathophysiological circumstances. In addition, the reparative effects of conservative medical and surgical interventions are discussed concisely, and an extensive overview is given on the regenerative therapies that are currently being explored. For the latter, the results of equine clinical studies might prove invaluable for gaining additional insights into the treatment of human tendinopathies, since not all of these novel regenerative therapies have been evaluated in humans yet.

Entities:  

Mesh:

Year:  2012        PMID: 22963225     DOI: 10.1007/BF03262300

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  176 in total

1.  A preliminary report on regenerative healing in the equine tendon.

Authors:  R D Norrie
Journal:  Am J Vet Res       Date:  1975-10       Impact factor: 1.156

2.  Cell therapy for tendon repair in horses: an experimental study.

Authors:  A Crovace; L Lacitignola; R De Siena; G Rossi; E Francioso
Journal:  Vet Res Commun       Date:  2007-08       Impact factor: 2.459

3.  Phenotypic drift in human tenocyte culture.

Authors:  L Yao; C S Bestwick; L A Bestwick; N Maffulli; R M Aspden
Journal:  Tissue Eng       Date:  2006-07

4.  Alternatives to the use of fetal bovine serum: human platelet lysates as a serum substitute in cell culture media.

Authors:  Caroline Rauch; Elisabeth Feifel; Eva-Maria Amann; Hans Peter Spötl; Harald Schennach; Walter Pfaller; Gerhard Gstraunthaler
Journal:  ALTEX       Date:  2011       Impact factor: 6.043

5.  Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons.

Authors:  Lauren V Schnabel; Hussni O Mohammed; Brian J Miller; William G McDermott; May S Jacobson; Kelly S Santangelo; Lisa A Fortier
Journal:  J Orthop Res       Date:  2007-02       Impact factor: 3.494

6.  Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children.

Authors:  Baijun Fang; Yongping Song; Quande Lin; Yanli Zhang; Ying Cao; Robert Chunhua Zhao; Yuanfang Ma
Journal:  Pediatr Transplant       Date:  2007-11

7.  Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells.

Authors:  Katharina Schallmoser; Christina Bartmann; Eva Rohde; Andreas Reinisch; Karl Kashofer; Elke Stadelmeyer; Camilla Drexler; Gerhard Lanzer; Werner Linkesch; Dirk Strunk
Journal:  Transfusion       Date:  2007-08       Impact factor: 3.157

8.  Mesenchymal stem cell therapy for equine tendinopathy.

Authors:  Roger K W Smith
Journal:  Disabil Rehabil       Date:  2008       Impact factor: 3.033

9.  Comparison of the incidence, nature and cause of injuries sustained on grass and new generation artificial turf by male and female football players. Part 2: training injuries.

Authors:  Colin W Fuller; Randall W Dick; Jill Corlette; Rosemary Schmalz
Journal:  Br J Sports Med       Date:  2007-08       Impact factor: 13.800

Review 10.  Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine.

Authors:  Thomas G Koch; Lise C Berg; Dean H Betts
Journal:  Can Vet J       Date:  2009-02       Impact factor: 1.008

View more
  13 in total

1.  Tenogenic induction of equine mesenchymal stem cells by means of growth factors and low-level laser technology.

Authors:  Chiara Gomiero; Giulia Bertolutti; Tiziana Martinello; Nathalie Van Bruaene; Sarah Y Broeckx; Marco Patruno; Jan H Spaas
Journal:  Vet Res Commun       Date:  2016-01-13       Impact factor: 2.459

2.  Peripheral Blood-Derived Mesenchymal Stromal Cells Promote Angiogenesis via Paracrine Stimulation of Vascular Endothelial Growth Factor Secretion in the Equine Model.

Authors:  Leen Bussche; Gerlinde R Van de Walle
Journal:  Stem Cells Transl Med       Date:  2014-10-13       Impact factor: 6.940

3.  Editorial: One Health and Veterinary Regenerative Medicine: Translational Applications.

Authors:  Tracy L Webb; Jan H Spaas; Debbie J Guest
Journal:  Front Vet Sci       Date:  2022-07-05

4.  Assessment of Clayey Peloid Formulations Prior to Clinical Use in Equine Rehabilitation.

Authors:  Carla Marina Bastos; Fernando Rocha; Ângela Cerqueira; Denise Terroso; Cristina Sequeira; Paula Tilley
Journal:  Int J Environ Res Public Health       Date:  2020-05-12       Impact factor: 3.390

5.  A novel mechanism for the protection of embryonic stem cell derived tenocytes from inflammatory cytokine interleukin 1 beta.

Authors:  Alyce McClellan; Richard Evans; Cheryl Sze; Shohei Kan; Yasmin Paterson; Deborah Guest
Journal:  Sci Rep       Date:  2019-02-26       Impact factor: 4.379

6.  Single-cell RNA sequencing of equine mesenchymal stromal cells from primary donor-matched tissue sources reveals functional heterogeneity in immune modulation and cell motility.

Authors:  Rebecca M Harman; Roosheel S Patel; Jennifer C Fan; Jee E Park; Brad R Rosenberg; Gerlinde R Van de Walle
Journal:  Stem Cell Res Ther       Date:  2020-12-04       Impact factor: 6.832

Review 7.  Regenerative Medicine for Equine Musculoskeletal Diseases.

Authors:  Iris Ribitsch; Gil Lola Oreff; Florien Jenner
Journal:  Animals (Basel)       Date:  2021-01-19       Impact factor: 2.752

8.  Regenerative therapies for equine degenerative joint disease: a preliminary study.

Authors:  Sarah Broeckx; Marieke Zimmerman; Sara Crocetti; Marc Suls; Tom Mariën; Stephen J Ferguson; Koen Chiers; Luc Duchateau; Alfredo Franco-Obregón; Karin Wuertz; Jan H Spaas
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

9.  Tenogenically Induced Allogeneic Mesenchymal Stem Cells for the Treatment of Proximal Suspensory Ligament Desmitis in a Horse.

Authors:  Aurélie Vandenberghe; Sarah Y Broeckx; Charlotte Beerts; Bert Seys; Marieke Zimmerman; Ineke Verweire; Marc Suls; Jan H Spaas
Journal:  Front Vet Sci       Date:  2015-10-22

10.  Tenogenically Induced Allogeneic Peripheral Blood Mesenchymal Stem Cells in Allogeneic Platelet-Rich Plasma: 2-Year Follow-up after Tendon or Ligament Treatment in Horses.

Authors:  Charlotte Beerts; Marc Suls; Sarah Y Broeckx; Bert Seys; Aurélie Vandenberghe; Jeroen Declercq; Luc Duchateau; Martin A Vidal; Jan H Spaas
Journal:  Front Vet Sci       Date:  2017-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.